VivoSeq
Other

Melatonin

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Melatonin is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

84/100

Attrition Rate

11/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

36

clinical trials

Completed21 · 58%
Unknown status10 · 28%
Terminated3 · 8%
Withdrawn1 · 3%
Recruiting1 · 3%

Trial Activity

36 trials

Oral Melatonin as Neuroprotectant in Preterm Infants
Completed··N/A·NCT04235673·60 enrolled
Melatonin in Adults With SMS
Completed·HHôpital le Vinatier·N/A·NCT03492970·10 enrolled
Melatonin Agonist for Shift-time Workers.
Completed·TTri-Service General Hospital·Phase 4·NCT07382843·61 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)